Capital DailyCapital Daily
Finance

Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?

Trulieve's price has soared this year, while Tilray's has plummeted, but which is the better stock right now?

Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?

Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?

Published June 12, 2026 · Category: Finance

Overview

Trulieve (OTC: TCNNF) last week saidthat it had received approval to list on the New York Stock Exchange (NYSE), making it the first U.S. cannabis company to be listed on a major exchange. It began trading on the NYSE under the ticker TRUL on June 10.

Its uplisting was made possible by the U.S. rescheduling of medical marijuana from a Schedule I to a Schedule III substance -- meaning it may have some medical benefits -- in April. After rescheduling, Trulieve made moves to consolidate its operations to consist solely of state-licensed medical marijuana facilities.

Details

The move is huge for the U.S. cannabis industry, but Canadian companies, such as Tilray (NASDAQ: TLRY), were already listed on U.S. major exchanges. Now that Trulieve and Tilray compete head-to-head on major exchanges, which is the better cannabis stock?

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.